We are live on ! Find out more
PHP

Parkman Healthcare Partners Portfolio holdings

AUM $970M
1-Year Est. Return 79.46%
This Fund
S&P 500
This Quarter Est. Return
+2.96%
1 Year Est. Return
+79.46%
3 Year Est. Return
+312.89%
5 Year Est. Return
+648.59%
10 Year Est. Return
–
AUM
$460M
AUM Growth
+$84.2M
Cap. Flow
+$106M
Cap. Flow %
23.1%
Top 10 Hldgs %
34.98%
Holding
99
New
18
Increased
56
Reduced
8
Closed
16

Top Buys

Rank Stock Value
1
COO icon
Cooper Companies
COO
+$14.6M
2
NBIX icon
Neurocrine Biosciences
NBIX
+$10.6M
3
BDX icon
Becton Dickinson
BDX
+$9.74M
4
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
+$9.13M
5
ZBH icon
Zimmer Biomet
ZBH
+$8.16M

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$14.7M
2
CNCE
Concert Pharmaceuticals, Inc.
CNCE
+$7.03M
3
DHR icon
Danaher
DHR
+$5.95M
4
RYTM icon
Rhythm Pharmaceuticals
RYTM
+$4.6M
5
SRPT icon
Sarepta Therapeutics
SRPT
+$4.58M

Sector Composition

Rank Sector Weight
1 Healthcare 99.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KRTX
26
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$7.14M 1.55%
39,307
+20,407
+108% +$3.9M
RXST icon
27
RxSight
RXST
$294M
$7.14M 1.55%
427,793
+251,372
+142% +$3.55M
PCVX icon
28
Vaxcyte
PCVX
$8.88B
$6.97M 1.52%
186,097
+28,049
+18% +$1.19M
NTRA icon
29
Natera
NTRA
$45.5B
$6.94M 1.51%
125,043
+71,551
+134% +$3.43M
MDGL icon
30
Madrigal Pharmaceuticals
MDGL
$12.4B
$6.26M 1.36%
25,840
+18,499
+252% +$5.04M
EVH icon
31
Evolent Health
EVH
$471M
$6.07M 1.32%
+186,923
New +$5.91M
MNKD icon
32
MannKind Corp
MNKD
$1.24B
$6.04M 1.31%
1,474,098
+442,989
+43% +$2.14M
IONS icon
33
Ionis Pharmaceuticals
IONS
$9.39B
$5.4M 1.18%
151,161
+10,046
+7% +$377K
DAWN
34
DELISTED
Day One Biopharmaceuticals
DAWN
$5.35M 1.16%
400,220
+175,737
+78% +$3.43M
PHLT
35
DELISTED
Performant Healthcare Inc
PHLT
$5.28M 1.15%
1,553,875
+234,200
+18% +$766K
STRO icon
36
Sutro Biopharma
STRO
$353M
$5.08M 1.11%
110,004
+23,406
+27% +$1.49M
BIIB icon
37
Biogen
BIIB
$30.9B
$4.98M 1.08%
17,920
+2,703
+18% +$748K
SUPN icon
38
Supernus Pharmaceuticals
SUPN
$2.78B
$4.78M 1.04%
131,878
+36,972
+39% +$1.42M
ACLX
39
DELISTED
Arcellx
ACLX
$4.55M 0.99%
147,646
+26,553
+22% +$805K
TGTX icon
40
TG Therapeutics
TGTX
$7.58B
$4.15M 0.9%
+275,641
New +$4.19M
ANIP icon
41
ANI Pharmaceuticals
ANIP
$1.73B
$3.97M 0.86%
100,000
-26,874
-21% -$1.13M
DHR icon
42
Danaher
DHR
$145B
$3.84M 0.83%
17,164
-26,143
-60% -$5.95M
ETNB
43
DELISTED
89bio
ETNB
$3.76M 0.82%
246,956
-85,924
-26% -$1.12M
WAT icon
44
Waters Corp
WAT
$40.9B
$3.67M 0.8%
11,867
+3,063
+35% +$991K
KRMD icon
45
KORU Medical Systems
KRMD
$152M
$3.59M 0.78%
851,375
+128,319
+18% +$505K
TVTX icon
46
Travere Therapeutics
TVTX
$5.86B
$3.19M 0.69%
141,887
+119,052
+521% +$2.53M
BCYC
47
Bicycle Therapeutics
BCYC
$284M
$3.14M 0.68%
147,799
+56,467
+62% +$1.42M
ESPR
48
DELISTED
Esperion Therapeutics
ESPR
$2.99M 0.65%
1,878,857
+1,056,073
+128% +$5.45M
IMVT icon
49
Immunovant
IMVT
$8.8B
$2.89M 0.63%
186,045
+28,039
+18% +$487K
KNSA icon
50
Kiniksa Pharmaceuticals
KNSA
$6.1B
$2.69M 0.59%
250,257
+58,950
+31% +$777K
1
2
3 4

Similar funds

LOIM
Liberty One Investment Management Libertyville, Illinois $970M AUM 12.15% 1-Year Est. Return
MGCM
Mane Global Capital Management New York $971M AUM 58.5% 1-Year Est. Return
JWM
Jackson Wealth Management Lake Mary, Florida $972M AUM 22.58% 1-Year Est. Return
WAM
WNY Asset Management Williamsville, New York $967M AUM
GHC
Graham Holdings Company Arlington, Virginia $967M AUM 15.12% 1-Year Est. Return
SAM
Stansberry Asset Management Westlake, Texas $973M AUM 21.39% 1-Year Est. Return
TCCM
Two Creeks Capital Management New York $974M AUM 2.54% 1-Year Est. Return
UIC
Uniplan Investment Counsel Milwaukee, Wisconsin $974M AUM 21.37% 1-Year Est. Return

Parkman Healthcare Partners's Q1 2023 Portfolio in Review

As of Q1 2023, Parkman Healthcare Partners held 99 positions worth $460M, up 22% from $376M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Parkman Healthcare Partners deployed $106M of net new capital in Q1 2023, opening 18 new positions and adding to 56 existing holdings. Its largest new stake was Becton Dickinson: 39,788 shares worth $9.85M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, up from 98% a quarter earlier.

On the sell side, the largest reduction was Danaher, an estimated $5.95M trimmed.

  • Parkman Healthcare Partners's largest Q1 2023 buy was Becton Dickinson: 39,788 shares worth $9.85M.
  • Parkman Healthcare Partners added most to Cooper Companies in Q1 2023, an estimated $14.6M increase.
  • Parkman Healthcare Partners's biggest Q1 2023 reduction was Danaher, cutting an estimated $5.95M.
  • Parkman Healthcare Partners fully exited UnitedHealth in Q1 2023, selling an estimated $14.7M.
  • Parkman Healthcare Partners's ten largest holdings make up 35% of its $460M portfolio in Q1 2023.
  • Parkman Healthcare Partners opened 18 new positions and closed 16 in Q1 2023.
  • Parkman Healthcare Partners's portfolio value rose 22% quarter-over-quarter to $460M.

Based on Parkman Healthcare Partners's 13F filing for Q1 2023, filed 12 May 2023.